The three big insulin makers, Novo Nordisk, Eli Lilly and Sanofi, must face a lawsuit that claims they gouged diabetes patients with the price of their lifesaving medications, according to Bloomberg.

A lawsuit filed in federal court on behalf of the University of Pennsylvania and its health system alleges that 20 years of skyrocketing prices on drugs that treat diabetes, like insulin, can be ...

Bucks County officials announced they are suing major insulin manufacturers and companies that negotiate drug price deals for insurers over an “illegal price-fixing scheme.” “Manufacturers ...

Eleven diabetes patients are suing several drug companies for alleged collusion on insulin pricing, reports The Washington Post. The lawsuit was filed Monday in U.S. District Court in ...

LPR has filed insulin price-fixing lawsuits on behalf of Lake County, Illinois; City of Cleveland; Monmouth County, New Jersey; and Albany County, New York. Attorneys who have filed lawsuits on ...

The Howard County Board of Education has joined the nationwide wave of lawsuits seeking to address the price of the diabetes drug insulin, which has skyrocketed in recent decades despite few ...

Texas Health Resources is suing major insulin manufacturers and pharmacy benefit managers over alleged artificial price inflation. The North Texas hospital system joins the list of over 400 ...

Mainers who rely on insulin will now be eligible to purchase monthly supplies of Sanofi insulin products through 2029 for $35 cash, under a new settlement announced by Attorney General Aaron Frey.

Maine Attorney General Aaron Frey announced a settlement agreement Tuesday with Sanofi-Aventis U.S. following scrutiny over the company’s pricing of insulin products.

Texas Health Resources is suing major insulin manufacturers and pharmacy benefit managers over alleged artificial price inflation. The North Texas hospital system joins the list of over 400 ...